Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$10.78 - $17.73 $177,870 - $292,545
-16,500 Closed
0 $0
Q3 2022

Aug 11, 2023

SELL
$8.63 - $15.52 $12,945 - $23,280
-1,500 Reduced 8.33%
16,500 $146,000
Q3 2022

Nov 03, 2022

SELL
$8.63 - $15.52 $12,945 - $23,280
-1,500 Reduced 8.33%
16,500 $146,000
Q2 2022

Aug 11, 2023

BUY
$8.59 - $20.77 $21,475 - $51,925
2,500 Added 16.13%
18,000 $227,000
Q2 2022

Aug 15, 2022

BUY
$8.59 - $20.77 $21,475 - $51,925
2,500 Added 16.13%
18,000 $228,000
Q1 2022

Aug 11, 2023

BUY
$15.52 - $35.65 $240,560 - $552,575
15,500 New
15,500 $293,000
Q1 2022

May 20, 2022

BUY
$15.52 - $35.65 $15,520 - $35,650
1,000 Added 6.9%
15,500 $293,000
Q4 2021

Feb 16, 2022

SELL
$28.89 - $35.33 $28,890 - $35,330
-1,000 Reduced 6.45%
14,500 $509,000
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $121,243 - $145,996
3,400 Added 28.1%
15,500 $567,000
Q2 2021

Aug 12, 2021

BUY
$23.7 - $39.27 $2,370 - $3,927
100 Added 0.83%
12,100 $475,000
Q1 2021

May 03, 2021

BUY
$27.01 - $36.8 $108,040 - $147,200
4,000 Added 50.0%
12,000 $339,000
Q4 2020

Feb 12, 2021

SELL
$27.51 - $34.36 $115,542 - $144,312
-4,200 Reduced 34.43%
8,000 $256,000
Q3 2020

Nov 09, 2020

SELL
$25.8 - $34.61 $2,580 - $3,461
-100 Reduced 0.81%
12,200 $394,000
Q2 2020

Aug 10, 2020

BUY
$17.65 - $28.05 $217,094 - $345,015
12,300 New
12,300 $345,000
Q1 2020

May 15, 2020

SELL
$15.19 - $29.51 $129,115 - $250,835
-8,500 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.17 - $25.95 $145,945 - $220,575
8,500 New
8,500 $213,000
Q2 2019

Aug 14, 2019

SELL
$22.0 - $31.78 $299,200 - $432,208
-13,600 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$21.27 - $30.58 $289,272 - $415,888
13,600 New
13,600 $416,000
Q3 2018

Nov 14, 2018

SELL
$26.55 - $34.38 $2.93 Million - $3.8 Million
-110,534 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$27.79 - $34.49 $1.8 Million - $2.24 Million
64,917 Added 142.31%
110,534 $3.33 Million
Q1 2018

May 15, 2018

SELL
$28.87 - $41.13 $1.68 Million - $2.39 Million
-58,182 Reduced 56.05%
45,617 $1.35 Million
Q3 2017

Nov 14, 2017

BUY
$22.15 - $27.5 $2.3 Million - $2.85 Million
103,799
103,799 $2.83 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.